Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight loss drug trial.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk stock surges 12% as an Ozempic alternative shows promising weight loss )
Also on site :
- Your new sofa could be the first sign tariff inflation is hitting home
- Nvidia on AI chip bans, OpenAI gets Jony Ive, and Google's Gemini in cars: Tech news roundup
- MBZUAI eröffnet Institut für Grundlagenmodelle und gründet Silicon Valley AI Lab